Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system

British Journal of Cancer

Volumn 78, Issue 4, 1998, Pages 446-453

  Kishima, H ^a   Shimizu, K ^a   Miyao, Y ^a   Mabuchi, E ^a   Tamura, K ^a   Tamura, M ^a   Sasaki, M ^a   Hayakawa, T ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Central nervous system; Interferon ; Interleukin 12; Malignant glioma; Tumour infiltrating lymphocytes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CERVICAL LYMPH NODE; CONTROLLED STUDY; GLIOBLASTOMA; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031875547     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.513     Document Type: Article

References (54)

1. Andrews JVR, Schoof DD, Bertagonalli MM, Peoples GE, Goedegebuure PS and Eberlein TJ (1993) Immunomodulatory effects of interleukin-12 on human tumor-infiltrating lymphocytes. J Immunother 14: 1-10
2. Annegers JF, Schoenberg BS, Okazaki H and Kurland LT (1981) Epidemiologic study of primary intracraninal neoplasm. Arch neurol 38: 217-219
3. Arita N, Taneda M and Hayakawa T (1994) Leptomcningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome. Acta Neurochir 126: 84-92
4. Barba D, Saris SC, Holder C, Rosenberg SA and Oldfield EH (1989) Intratumoral LAK cell and interleukin-2 therapy of human gliomas. J Neurosurg 70: 175-182
5. Bloom ET and Horvath JA (1994) Cellular and molecular mechanism of the IL-12-induced increase in allospecific murine cytolytic T cell activity. J Immunol 152: 4242-4254
6. Brunda MJ (1994) Interleukin-12. J Leukoc Biol 55: 280-288
7. Brunda MJ and Gately MK (1994) Antitumor activity of interlcukin-12. Clin Immunol Immunother 71: 253-255
8. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF and Gately MK (1993) Antitumor and antimelastatic activity of interleukin 12 against nuirine tumors. J Exp Med 178: 1223-1230
9. Cesano A, Visonneau S and Santoli D (1995) Treatment of experimental glioblastoma with a human major histocompatibility complex non-restrieted cytotoxic T cell line. Cancer Rec 55: 96-101
10. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC and Trinchieri G (1991) Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 173: 869-879
11. Cserr HF, Harling Berg CJ and Knopf PM (1992) Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol 2: 269-276
12. de Micco C (1989) Immunology of central nervous system tumors. J Neuroimmunol 25: 93-108
13. Färkkilä M. Jääskeläinen J, Kallio M, Blomstedt G, Raininko R, Virkkunen P, Paetau A, Sarelin H and Mäntrylä M (1994) Randomized, controlled study of intratumoral recombinant γ-interferon treatment in newly diagnosed glioblastoma. Br J Cancer 70: 138-141
14. Finkelman FD, Madden KB, Cheever AW, Katona IM, Morris SC, Gately MK, Hubbard BR, Gause WC and Urban Jr. JF (1994) Effect of interleukin 12 on immune response and host Protection in mice infected with intestinal nematode paresis. J Exp Med 179: 1563-1572
15. Fontana A, Hengatner H, de Tribolet N and Weber E (1984) Glioblastoma cells release interleukin I and factors inhibiting interleukin 2-mediated effects. J Immunol 132: 1837-1844
16. Fontana A, Frei K, Bodmer S and Hofer E (1987) Immune-mediated encephalitis: on the role of antigen-presenting cells in brain tissue, Immunol Rev 100: 185-201
17. Frank E, Pulver M and de Tribotel N (1986) Expression of class II major histocompatibility antigens on reactive astrocytes and endothelial cell within the gliosis surrounding metastases and abscesses. J Neurommunol 12: 29-36
18. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C and Fontana A (1987) Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells, Eur J Immunol 17: 1271-1278
19. Gately MK, Warrier RR, Honasoge S, Carvajal DM, Faherty DA, Connaughton SE, Anderson TD, Sarmiento U, Hubbard BR and Murphy M (1994) Administration of recombinant IL-12 to normal mice enhances cytolytic Iymphocyte activity and induces production of IFN-γ in vivo. Int Immunol 6: 157-167
20. Gerosa F, Paganin C, Peritt D, Paiola F, Scupoli MT, Aste-Amezaga M, Frank I and Trinchieri G (1996) Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J Exp Med 183: 2559-2569
21. Hasbimoto W, Takeda K, Anzai K, Ogasawara K, Sakihara H, Sugiura K, Seki S and Kumagai K (1995) Cytoloxic NKI.1 Ag α β T cells with intermediate TCR induced in the liver of mice by 1L-12. J Immunol 154: 4333-4340
22. Hickey WF, Vass K and Lassmann H (1992) Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructual survey of rat chimeras. J Neuropathol 51: 246-256
23. Kennedy MK, Picha KS, Shanebeck KD, Anderson DM and Grabstein KH (1994) Interleukin-12 regulates the proliferation of Th1. but not Th2 or Th0. clones. Eur J Immunoal 24: 2271-2278
24. Kida S, Pantazis A and Weller RO (1993) CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance, Neuropathol Appl Neurobiol 19: 480-488
25. Kida S, Weller RO, Zhang E-T, Phillips MJ and Iannotti F (1995) Anatomical pathways for lymphatic drainage of the brain and their pathological significance. Neuropathol Appl Neurobiol 21: 181-184
26. Kitamura I, Kochi M, Matsumoto Y, Ueoka R, Kuratsu JI and Ushio Y (1996) Intrathecal chemotherapy with 1.3-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposome for meningeal gliomatosis: an experimental study. Cancer 56: 3986-3992
27. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, London R, Sherman F, Perussia B and Trinchieri G (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokinc with multiple biologic effects on human lymphocytes, J Exp Med 170: 827-845
28. Kumanishi T, Ikuta F and Yamamoto T (1973) Brain tumors induced by Rous sarcoma virus. Schmidt-Ruppin stain. III. Morphology of brain tumors induced in adult mice. J Natl Cancer Inst 51: 95-109
29. Lee SC, Lie W, Brosan CF and Dickson DW (1994) GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia 12: 309-318
30. Lillehei KO, Mitchell DH, Johnson SD, McCleary EL and Kruse CA (1991) Long-term follow up of patients with recurrent malignant gliomas treated with adjuvant adoptive immunotherapy. Neurosurgery 28: 16-23
31. Marshall JD, Secrist H, DeKruyff RH, Wolf SF and Umetsu DT (1995) IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocyte. J Immunol 155: 111-117
32. Martinotti A, Stoppacciaro A, Vagliani M, Melani C, Spreafico F, Wysocka M, Parmiani G, Trinchieri G and Colombo MP (1995) CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Eur J Immunol 25: 137-146
33. Matsumoto Y, Ohmori K and Fujiwara M (1992) Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cell under in vivo-mimicking condition. Immunology 76: 209-216
34. Mu J, Zou J-P, Yamamoto N, Tsutsui T, Tai X-G., Kobayashi M, Herrmann S, Fujiwara H and Hamaoka T (1995) Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res 55: 4404-4408
35. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Wolf SF, Gately MK, Schreiber RD, Storkus WJ and Lotze MT (1994) Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J Immunol 153: 1697-1706
36. Nazzro JM and Neuwelt EA (1990) The role of surgery in the management of supratenotrial intermediate and high-grade astrocytoma in adults. J Neurosurg 73: 331-344
37. Nitta T, Sato K, Yagita H, Okumura K and Ishii S (1990) Preliminary trial of specific targeting therapy against malignant glioma. Lancet 335: 368-376
38. Ohno K, Susumura A, Sawada M and Marunouchi T (1990) Production of granulocyte/macrophage colony-stimulating factor by cultured astrocytoma. Biochem Biophys Res Commun 169: 719-724
39. Rapp UR, Nowinski RC, Reznikoff CA and Heidelberger C (1975) Endogenous oneornaviruses in chemically induced transformant. Virology 65: 392-409
40. Sawamura Y, Abe H, Aida T, Hosokawa M and Kobayashi H (1988) Isolation and in vitro growth of glioma-infiltrating lymphocytes, and an analysis of surface phenotypes. J Neurosurg 69: 745-750
41. Schoenhaut DS, Chua AO, Wolitzky AG, Quinn PM, Dwyer CM, McComas W, Familletti PC, Gately MK and Gubler U (1992) Cloning and expression of murine IL-12. J Immunol 148: 3433-3440
42. Seder RA, Gazzinelli R, Sher A and Paul WE (1993) Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon γ production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 90: 10188-10192
43. Shimizu K, Okamoto Y, Miyao Y, Yamada M, Ushin Y, Hayakawa T, Ikeda H and Mogami H (1987) Adoptive immunotherapy of human meningeal gliomatosis and carcinomatosis with LAK cells and recombinant interleukin-2. J Neurosurg 66: 519-521
44. Shrikant P and Benveniste N (1996) The central nervous system as an immunocompetent organ. J Immunol 157: 1819-1821
45. Stern AS, Podlasky FJ, Hulmes JD, Pan YCE, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chezzonile R and Gatel MK (1990) Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 87: 6808-6812
46. Tahara H and Lotze MT (1995) Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Gene Therapy 2: 96-106
47. Tahara H, Zeh III HJ, Storkus WJ, Pappo I, Waltkins SC, Gubler U, Wolf SF, Robbins PD and Lotze MT (1994) Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to murine melanoma in vivo. Cancer Res 54: 182-189
48. Tamura K, Shimizu K, Yamada M, Okamoto Y, Matsui Y, Park KC, Mabuchi E, Moriuchi S and Mogami H (1989) Expression of major histocompatibility complex on human medulloblastoma cells with neuronal differentiation. Cancer Res 49: 5380-5384
49. UKCCR (1988) UKCCR guidelines for the welfare of animals in experimental neoplasia. Br J Cancer 58: 109-113
50. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, Kelleher K, Herrmann SH, Clark SC, Azzoni L, Chng SH, Trinchieri G and Perussia B (1991) Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 146: 3074-3081
51. Wong GHW, Bartlett PF, Clark-Lewis I, Battye F and Schrader JW (1984) Inducible expression of H-2 and la antigens on brain cells. Nature 310: 688-691
52. Yamada M, Shimizu K, Miyao Y, Hayakawa T, Nakajima K, Nakahira K, Nakagawa H, Mikoshiba K and Ikenaka K (1994) Migration of genetically labeled glioma cells after implantation into murine brain. J Neurosci Res 38: 415-423
53. Yoshida J, Kajita Y, Wakabayashi T and Sugita K (1994) Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumor resection and postoperative adjuvant therapy with interferon. ACNU and radiation. Acta Neurochir 127: 55-59
54. Zitvogel L, Robbins PD, Storkus WJ, Clarke MR, Maeurer MJ, Campbell RL, Davis CG, Tahara H, Schreiber RD and Lotze MT (1996) Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Eur J Immunol 26: 1335-1341